Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy
Authors:
- 31 May 2021
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 99 (9) , 1311-1321
Abstract
Circulating tumor DNA (ctDNA) is considered an ideal sample type for genotyping patients with advanced unresectable cancer to inform treatment decision. ItKeywords
Funding Information
- The capital health research and development of special (2018-2-1023)
- the Pilot Project (3rd Round) to Reform Public Development of Beijing Municipal Medical Research Institutes (2019-1)
This publication has 47 references indexed in Scilit:
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targetsNature Communications, 2015
- Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapyProceedings of the National Academy of Sciences, 2015
- Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencingNature Communications, 2014
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- Identification of genomic alterations in oesophageal squamous cell cancerNature, 2014
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesScience Translational Medicine, 2014
- Charles Emmanuel Sédillot and Émile Küss: The first cancer biopsyInternational Journal of Surgery, 2013
- Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase FusionsClinical Cancer Research, 2012
- Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human CholangiocarcinomaPLOS ONE, 2011
- Clinicopathologic characteristics and outcomes of gastric cancers with the MSI‐H phenotypeJournal of Surgical Oncology, 2008